Sign up to Seedtable
Get unlimited access to our database of 17,248 companies. Cancel anytime.
Full database access with no contact information. New companies added weekly.
- Access 17k companies (and growing) with unlimited exports
- Filter by geography, business model, industry, money raised and more
- Score to find fast-growing companies
- Likely to Outsource tag to understand if a company is looking for your services
- Verified email addresses so you can contact people directly
- Personalized 1:1 onboarding by a cold email expert
Full database access with verified contact info. New companies added weekly.
- Access 17k companies (and growing) with unlimited exports
- Filter by geography, business model, industry, money raised and more
- Score to find fast-growing companies
- Likely to Outsource tag to understand if a company is looking for your services
- Verified email addresses so you can contact people directly
- Personalized 1:1 onboarding by a cold email expert
All of Pro, plus we'll exclude your top three competitors as new Intel customers.
- Access 17k companies (and growing) with unlimited exports
- Filter by geography, business model, industry, money raised and more
- Score to find fast-growing companies
- Likely to Outsource tag to understand if a company is looking for your services
- Verified email addresses so you can contact people directly
- Personalized 1:1 onboarding by a cold email expert
Free plan includes the ability to browse the database and a list of the top 10 companies of the week, every Tuesday in your email. You need to upgrade if you want to see more than 10 companies, sort, filter or export data.
world-class organizations
69 Health Tech Startups in Cambridge to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Surgical robotic system for minimal access surgery. |
$164M · Series D | SoftBank Group, Tencent, ABB Technology Ventures | 501 to 1000 | Health Tech, Robotics | B2B | Cambridge, UK | •••••••••••@cmrsurgical.com | |
AI platform to advance precision medicine clinical trials. |
$11M · Series A | Seedcamp, Plural, MMC Ventures | 11 to 50 | Health Tech, Biotech | B2B, SaaS | Cambridge, UK | •••••••••••@sanogenetics.com | |
Drug delivery platform. |
$24M · Series A | 4BIO Capital, UCB Ventures, Business Growth Fund | 1 to 10 | Health Tech, Biotech | Cambridge, UK | •••••••••••@vianautis.com | ||
Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. |
$66M | Cambridge Innovation Capital, Seventure Partners | 11 to 50 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@microbiotica.com | |
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases. |
$56M · Series B | Balderton Capital, Atomico, btov Partners | 51 to 100 | Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@healx.io | |
Transforming mental healthcare by unlocking the power of clinical data |
$52M · Series B | Molten Ventures | 101 to 250 | Health Tech, Deep Tech | B2B, B2C | Cambridge, UK | •••••••••••@iesogroup.com | |
Small molecule neoantigen immuno-oncology therapies developer. |
$12M · Series B | Sixth Element Capital, 3B Future Health Fund, Astellas Venture Management | 1 to 10 | Health Tech | Cambridge, UK | •••••••••••@neophore.com | ||
Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies. |
$10M · Series A | Astellas Venture Management, Ahren Innovation Capital, Parkwalk Advisors | 101 to 250 | Health Tech, Biotech, Deep Tech | B2B | Cambridge, UK | •••••••••••@mogrify.co.uk | |
Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. |
$41M · Series A | Metaplanet Holdings, BlueYard Capital | 101 to 250 | Health Tech, Biotech, Deep Tech, Business Intelligence | B2B | Cambridge, UK | •••••••••••@bit.bio | |
Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology. |
$11M · Seed | GV, Forbion Capital Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@mestagtx.com | |
Genomics company building safer cell and gene therapies. |
$15M · Series A | Tencent, Illumina Ventures | 1 to 10 | Health Tech, Biotech | Cambridge, UK | •••••••••••@brokenstringbio.com | ||
Cake is the world's largest platform for helping people navigate end-of-life. |
$14M | Creandum, Headline | 1 to 10 | Health Tech, Mobile, Mobility & Transportation, Manufacturing, Sales and Marketing | B2C | Cambridge, UK | •••••••••••@joincake.com | |
Physiological upregulation therapy to treat neurodegenerative diseases. |
$5M · Seed | SV Health Investors | 11 to 50 | Health Tech, Biotech | Cambridge, UK | •••••••••••@harnesstx.com | ||
Supplant is a biotechnology platform that makes sugar substitutes. |
$24M | Khosla Ventures, Felicis Ventures, Y Combinator | 11 to 50 | Health Tech, Foodtech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@supplant.com | |
Cancer diagnostics. |
$16M · Series A | Business Growth Fund | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@cyted.ai | ||
Eagle Genomics is a enterprise software solutions company to enable the management, orchestration and exploitation of life sciences data. |
$3M · Seed | ETF Partners, Granpool Innovative Investments | 11 to 50 | Health Tech, Biotech | B2B | Cambridge, UK | •••••••••••@eaglegenomics.com | |
Endomag is a medical technology company devoted to improving breast cancer care through its magnetic sensing technologies. |
$20M · Series D | Molten Ventures | 51 to 100 | Health Tech, Hardware | B2B | Cambridge, UK | •••••••••••@endomag.com | |
Metrion Biosciences is a Contract Research Organization. |
$4M · Series A | Gresham House Ventures, NPIF Maven Equity Finance | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@metrionbiosciences.com | ||
AI-driven tech for respiratory conditions. |
$9M · Series A | Business Growth Fund, Downing Ventures | 11 to 50 | Health Tech, AI | Cambridge, UK | •••••••••••@tidalsense.com | ||
Biofidelity developed a revolutionary molecular diagnostics. |
$12M · Series A | Octopus Ventures, BlueYard Capital | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Cambridge, UK | •••••••••••@biofidelity.com | |
PetMedix is a pet therapeutics startup. |
$13M · Series A | Cambridge Innovation Capital, Parkwalk Advisors | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@petmedix.co.uk | |
Precision software for surgeries. |
$11M · Series A | Pembroke VCT | 11 to 50 | Health Tech | B2B, SaaS | Cambridge, UK | •••••••••••@cydarmedical.com | |
Sphere Fluidics develops products for use in single cell analysis and characterization, and provides associated collaborative R&D services. |
$4M | Sofinnova Partners | 11 to 50 | Health Tech, Deep Tech | B2B | Cambridge, UK | •••••••••••@spherefluidics.com | |
PillSorted is a Pharmacy, blending compassionate care and innovative technology to deliver a truly Personal Pharmacy service. |
$6M · Seed | Hoxton Ventures | 11 to 50 | Health Tech, CPG & Consumer Goods, Pharma, Ecommerce | B2B, B2C, SaaS | Cambridge, UK | •••••••••••@pillsorted.com | |
Epitopea is a transatlantic cancer immunotherapeutics company. |
$13M · Seed | Cambridge Innovation Capital | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@epitopea.com | |
Drug manufacturer. |
$10M · Series A | Biospring Partners | 501 to 1000 | Health Tech, Biotech, Pharma | B2B, SaaS | Cambridge, UK | •••••••••••@abzena.com | |
Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers. |
$5M | Calculus Capital | 11 to 50 | Health Tech, Biotech, Pharma, Business Intelligence | B2B | Cambridge, UK | •••••••••••@axolbio.com | |
Owlstone Medical is a diagnostics company that developed a non-invasive breathalyzer for infectious disease detection. |
$57M · Series D | 101 to 250 | Health Tech | Cambridge, UK | •••••••••••@owlstonemedical.com | |||
Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies. |
$152M · Series C | 101 to 250 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@artiospharma.com | |||
Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw. |
$88M · Series D | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@cambridge-epigenetix.com | |||
Treatment for patients with chronic wounds. |
$13M · Series B | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@solascure.com | |||
PhoreMost is a new-model drug discovery company based in Cambridge, UK. |
$45M · Series B | 1 to 10 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@phoremost.com | |||
Novel cancer therapies. |
$30M · Series B | 11 to 50 | Health Tech, Deep Tech | B2C | Cambridge, UK | •••••••••••@stormtherapeutics.com | ||
Semarion leverages microfabrication technology to build smart materials and develop novel cell assaying applications. |
$2M · Seed | Parkwalk Advisors, Martlet Capital | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | Cambridge, UK | •••••••••••@semarion.com | |
NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function. |
$18M | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Cambridge, UK | •••••••••••@nrgtherapeutics.com | ||
Charco Neurotech is a medical technology company that develops non-invasive wearable devices. |
$692k · Pre Seed | Amadeus Capital, Parkwalk Advisors | 11 to 50 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Cambridge, UK | •••••••••••@charconeurotech.com | |
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance. |
$9M | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@phicotx.co.uk | |||
Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis. |
$7M · Series A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@predictimmune.com | |||
Transine Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs. |
$12M · Seed | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Cambridge, UK | •••••••••••@transinetx.com | ||
Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases. |
$16M | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@wrentherapeutics.com | |||
PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders. |
$1M | Parkwalk Advisors, Martlet Capital | 11 to 50 | Health Tech, Biotech, Data and Analytics | B2B, SaaS | Cambridge, UK | •••••••••••@psyomics.com | |
Qureight is an imaging analytics company. |
$637k · Seed | Playfair Capital, Ascension Ventures, CMS Ventures | 1 to 10 | Health Tech, Machine Learning, Data and Analytics | B2B, SaaS | Cambridge, UK | •••••••••••@qureight.com | |
Clinical stage studies to discover biomarkers to improve medical diagnosis. |
$2M · Seed | 1 to 10 | Health Tech, Biotech | Cambridge, UK | •••••••••••@upfrontdiagnostics.com | |||
Spirea Ltd. operates as a healthcare technology company. |
$2M | Health Tech | Cambridge, UK | •••••••••••@spirea.co.uk | ||||
Transforming the way a nation delivers its healthcare to its population, from prescriptions to personalised services. |
$604k | Innovate UK | 11 to 50 | Health Tech | Cambridge, UK | •••••••••••@healthera.co.uk | ||
Monocl empowers life science professionals with the complete global expert solution for impactful outreach and strategic engagement. |
$3M | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@monocl.com | ||
PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery. |
$2M · Seed | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@pharmenable.com | ||
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery. |
$1M · Pre Seed | 1 to 10 | Health Tech, AI, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@cardiatec.ai | ||
Spotta is a provider of smart pest systems. |
$1M · Seed | Martlet Capital | 1 to 10 | Health Tech, Manufacturing, Community & Lifestyle | B2C | Cambridge, UK | •••••••••••@spotta.co | |
Congenica is a biotechnology company that provides a diagnostic decision support platform. |
N/A | Cambridge Innovation Capital, Parkwalk Advisors, QVentures | 11 to 50 | Health Tech, Biotech, Genetics | B2B | Cambridge, UK | •••••••••••@congenica.com | |
52 North Health is developing a fully-integrated clinical, AI-driven medical device-based system called NeutroCheck for people with cancer. |
$1M · Seed | 1 to 10 | Health Tech, Hardware, AI, Manufacturing | B2B | Cambridge, UK | •••••••••••@52north.health | ||
Legacy is a digital fertility clinic for men, founded at Harvard & backed by Y Combinator, FirstMark Capital, Bain Capital and celebrities. |
N/A | 101 to 250 | Health Tech, Biotech, Proptech & Real Estate, Femtech, Mobile, Energy & Nuclear, Genetics, Business Intelligence, Fertility | B2B, SaaS | Cambridge, UK | •••••••••••@givelegacy.com | ||
AI extracting health data from sound. |
$585k · Pre Seed | 1 to 10 | Health Tech, Hardware, AI, Machine Learning, Manufacturing | B2B | Cambridge, UK | •••••••••••@decorte.co.uk | ||
Molecular therapies for cancer patients. |
N/A | 11 to 50 | Health Tech, Deep Tech | B2C | Cambridge, UK | •••••••••••@acaciapharma.com | ||
Kirontech uses cutting edge machine learning technology to revolutionize the use of healthcare data. |
N/A | 11 to 50 | Health Tech, Data and Analytics | Cambridge, UK | •••••••••••@kirontech.com | |||
Lab 21 supports healthcare providers and the pharmaceutical and biotechnology industries with technically advanced testing services. |
N/A | 51 to 100 | Health Tech | Cambridge, UK | •••••••••••@lab21.com | |||
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. |
N/A | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@f-star.com | |||
Exonate is a biotech company spun out of the University of Nottingham that is focused on alternative splicing of (VEGF) in ophthalmology. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@exonate.com | |||
Produce pure, mature and highly consistent batches of human cell types for research, toxicology and drug development. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@elpis.ltd | |||
MISSION Therapeutics offers a platform for the development of small molecule drugs that selectively target deubiquitylating enzymes (DUBs). |
N/A | 11 to 50 | Health Tech, Biotech, Deep Tech | Cambridge, UK | •••••••••••@missiontherapeutics.com | |||
Definigen provides human cells to the drug discovery sector for use in lead optimization and toxicity programs. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@definigen.com | |||
MORPHOGEN-IX Limited is a drug discovery company founded in 2015 by Index Ventures to develop bone morphogenetic proteins |
N/A | 1 to 10 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@morphogen-ix.com | |||
Mursla is a quantum biology diagnostics company. |
N/A | 11 to 50 | Health Tech | Cambridge, UK | •••••••••••@mursla.com | |||
Nemesis Bioscience is a new biopharmaceutical company . |
N/A | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@nemesisbio.com | ||||
OKRA is an AI analytics company for healthcare. We combine complex data sets, you get evidence-based insights and predictions in real time. |
N/A | 11 to 50 | Health Tech, Data and Analytics | Cambridge, UK | •••••••••••@okra.ai | |||
Patients Know Best provide hospitals with personal health records software so that their patients can better manage their health. |
N/A | 101 to 250 | Health Tech | Cambridge, UK | •••••••••••@patientsknowbest.com | |||
PetaGene’s mission is to make genomics data cheaper, faster and better. |
N/A | 1 to 10 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@petagene.com | |||
CS Genetics develops new technology for genomics, based on scientific insights and conceptual innovations in NGS techniques. |
N/A | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@csgenetics.com | |||
Crescendo Biologics is engaged in the development of a proprietary drug portfolio based on their VH antibody fragment platform. |
N/A | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@crescendobiologics.com |
Sign up to access our full database
Enter your email and get access to 17,000+ technology companies you can partner with.